APA
Rinehart J., Adjei A. A., Lorusso P. M., Waterhouse D., Hecht J. R., Natale R. B., Hamid O., Varterasian M., Asbury P., Kaldjian E. P., Gulyas S., Mitchell D. Y., Herrera R., Sebolt-Leopold J. S. & Meyer M. B. (20041208). Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Rinehart John, Adjei Alex A, Lorusso Patricia M, Waterhouse David, Hecht J Randolph, Natale Ronald B, Hamid Oday, Varterasian Mary, Asbury Peggy, Kaldjian Eric P, Gulyas Stephen, Mitchell David Y, Herrera Roman, Sebolt-Leopold Judith S and Meyer Mark B. 20041208. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Rinehart J., Adjei A. A., Lorusso P. M., Waterhouse D., Hecht J. R., Natale R. B., Hamid O., Varterasian M., Asbury P., Kaldjian E. P., Gulyas S., Mitchell D. Y., Herrera R., Sebolt-Leopold J. S. and Meyer M. B. (20041208). Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Rinehart John, Adjei Alex A, Lorusso Patricia M, Waterhouse David, Hecht J Randolph, Natale Ronald B, Hamid Oday, Varterasian Mary, Asbury Peggy, Kaldjian Eric P, Gulyas Stephen, Mitchell David Y, Herrera Roman, Sebolt-Leopold Judith S and Meyer Mark B. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20041208.